Tag Archive > Cardiology Department

Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets

Barcelona, Spain (ots/PRNewswire) – – New Cobalt Chromium Stent Offers Enhanced Deliverability with a Broad Matrix of Sizes – Built Upon the Proven Track Record of Superior Clinical Outcomes of Abbott’s Market-Leading XIENCE V(R) Drug Eluting Stent Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Landmark EchoCRT trial enrolls first European patients

(pressebox) Berlin, 02.12.2008 – BIOTRONIK announces European rollout of the EchoCRT Trial investigating the life-saving benefits of cardiac resynchronization therapy in patients with heart failure who currently do not receive device therapy. BIOTRONIK announced that the first European patients have been enrolled into the EchoCRT (Echocardiography guided Cardiac Resynchronization Therapy) trial by the team of [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,